PIK3CA and neoplasm: Relatively frequent gains in 7p and 11p as well as losses in 14q and 15q were associated with worse outcome and tumor progression, as were alterations in the Notch pathway and PI3K-AKT pathway, NOTCH1, PIK3CA, PIK3R1, and ARID1A [36,45,93].